16 results
Search Results
2. Childhood cancer survivor cohorts in Europe.
- Author
-
Winther, Jeanette F., Kenborg, Line, Byrne, Julianne, Hjorth, Lars, Kaatsch, Peter, Kremer, Leontien C. M., Kuehni, Claudia E., Auquier, Pascal, Michel, Gérard, de Vathaire, Florent, Haupt, Riccardo, Skinner, Roderick, Madanat-Harjuoja, Laura M., Tryggvadottir, Laufey, Wesenberg, Finn, Reulen, Raoul C., Grabow, Desiree, Ronckers, Cecile M., van Dulmen-den Broeder, Eline, and van den Heuvel-Eibrink, Marry M.
- Subjects
CANCER chemotherapy ,CANCER patients ,MEDICAL screening ,QUALITY of life ,RADIOTHERAPY ,DISEASE complications ,TUMORS in children ,TUMOR treatment - Abstract
With the advent of multimodality therapy, the overall five-year survival rate from childhood cancer has improved considerably now exceeding 80% in developed European countries. This growing cohort of survivors, with many years of life ahead of them, has raised the necessity for knowledge concerning the risks of adverse long-term sequelae of the life-saving treatments in order to provide optimal screening and care and to identify and provide adequate interventions. Childhood cancer survivor cohorts in Europe. Considerable advantages exist to study late effects in individuals treated for childhood cancer in a European context, including the complementary advantages of large population-based cancer registries and the unrivalled opportunities to study lifetime risks, together with rich and detailed hospital-based cohorts which fill many of the gaps left by the large-scale population-based studies, such as sparse treatment information. Several large national cohorts have been established within Europe to study late effects in individuals treated for childhood cancer including the Nordic Adult Life after Childhood Cancer in Scandinavia study (ALiCCS), the British Childhood Cancer Survivor Study (BCCSS), the Dutch Childhood Oncology Group (DCOG) LATER study, and the Swiss Childhood Cancer Survivor Study (SCCSS). Furthermore, there are other large cohorts, which may eventually become national in scope including the French Childhood Cancer Survivor Study (FCCSS), the French Childhood Cancer Survivor Study for Leukaemia (LEA), and the Italian Study on off-therapy Childhood Cancer Survivors (OTR). In recent years significant steps have been taken to extend these national studies into a larger pan-European context through the establishment of two large consortia - PanCareSurFup and PanCareLIFE. The purpose of this paper is to present an overview of the current large, national and pan-European studies of late effects after childhood cancer. This overview will highlight the strong cooperation across Europe, in particular the EU-funded collaborative research projects PanCareSurFup and PanCareLIFE. Overall goal. The overall goal of these large cohort studies is to provide every European childhood cancer survivor with better care and better long-term health so that they reach their full potential, and to the degree possible, enjoy the same quality of life and opportunities as their peers. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. Theoretical and practical outline of the Copenhagen PACT narrative-based exercise counselling manual to promote physical activity in post-therapy cancer survivors.
- Author
-
Midtgaard, Julie
- Subjects
TUMOR treatment ,CANCER patients ,CONCEPTUAL structures ,COUNSELING ,TUMORS ,SOCIAL support ,PHYSICAL activity ,DISEASE complications - Abstract
Background. Sedentary behaviour and reduced exercise capacity are potential persisting effects of anti-cancer therapy that may predispose to serious health conditions. It is well-established that physical exercise may prevent some of these problems. However, the extent to which cancer survivors are able to adopt long-term physical activity habits depends largely on their motivation. Aim. This theoretical paper aims to outline how researchers and practitioners can draw from Antonovsky's salutogenetic theory and White & Epston's Narrative Therapy to develop and implement intervention efforts centered on promotion of long-term physical activity behaviour, while at the same time increasing the individual cancer survivor's sense of meaning and personal health resources. Material and methods. The Copenhagen PACT (Physical Activity after Cancer Treatment) Study targeting adoption and maintenance of regular physical activity in post-therapy cancer survivors is briefly presented including a brief review of the theoretical rationale behind the psychological component of the intervention, i.e. a narrative-based exercise counselling programme. Subsequently, particular attention is given to the core principles, different components and structure of the counselling manual including sample questions and examples of written documents that have emanated from the individual counselling sessions. Discussion. The discussion includes consideration of some methodological challenges that arise when attempting to evaluate narrative-based interventions in the context of physical activity promotion in cancer rehabilitation and survivorship care. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
4. Some musculo-skeletal sequelae in cancer survivors.
- Author
-
Aksnes, Liv Hege and Bruland, Øyvind Sverre
- Subjects
CANCER patients ,PROSTATE cancer ,BREAST cancer ,DISEASE complications ,DRUG therapy ,CANCER treatment - Abstract
This paper deals with some of the musculo-skeletal complication that can occur after cancer treatment. In particular, we focus on Cancer Treatment Induced Bone Loss (CTIBL) and the musculo-skeletal complications that can occur in patients treated for extremity sarcoma. In addition we discuss peripheral neuropathy, musculo-skeletal pain and briefly mention some of the complications related to radiotherapy. CTIBL is mostly studied in breast cancer and prostate cancer survivors. The cause in these groups is mainly due to treatment induced hypogonadism. Other causes of CTIBL are indirect or direct cause of chemotherapy, physical inactivity and inadequate intake of vitamin D and calcium. Treatment of CTIBL consists of diet and lifestyle changes and pharmacological intervention. Extremity bone sarcomas constitute a special group since they often experience mutilating surgery and heavy combination chemotherapy. The treatment results in worse function than the normal population and the amputated usually have lower physical functioning than patients treated with limb sparing surgery (LSS). However, most studies fail to show differences in quality of life between the amputated and LSS. Most of the studies performed on musculo-skeletal sequelae have been done on survivors of childhood cancer, breast cancer or prostate cancer. More studies among the other cancer groups are needed to reveal the extent and prevalence of these complications. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
5. Symptoms of posttraumatic stress disorder and adjustment disorder in hematological cancer patients with different treatment regimes.
- Author
-
Springer, Franziska, Kuba, Katharina, Ernst, Jochen, Friedrich, Michael, Glaesmer, Heide, Platzbecker, Uwe, Vucinic, Vladan, Heyne, Svenja, Mehnert-Theuerkauf, Anja, and Esser, Peter
- Subjects
STEM cell transplantation ,ANALYSIS of variance ,CROSS-sectional method ,SELF-evaluation ,POST-traumatic stress disorder ,REGRESSION analysis ,CANCER patients ,RISK assessment ,COMPARATIVE studies ,HEMATOLOGIC malignancies ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,CHI-squared test ,RESEARCH funding ,SOCIODEMOGRAPHIC factors ,HEMATOPOIETIC stem cell transplantation ,ADJUSTMENT disorders ,COMORBIDITY ,DISEASE complications - Abstract
Symptoms of posttraumatic stress disorder (PTSD) and adjustment disorder (AjD) are common in hematological cancer patients as they face severe stressors during their serious disease and often intensive treatment, such as stem cell transplantation (SCT). Aims of the present study were to provide frequency and risk factors for PTSD and AjD based on updated diagnostic criteria that are lacking to date. In a cross-sectional study, hematological cancer patients were assessed for stressor-related symptoms via validated self-report questionnaires based on updated criteria for PTSD (PCL-5) and AjD (ADMN-20). Frequency and symptom severity were estimated among the total sample and SCT subgroups (allogeneic, autologous, no SCT). SCT subgroups were compared using Chi-squared-tests and ANOVAs. Linear regression models investigated sociodemographic and medical factors associated with symptomatology. In total, 291 patients were included (response rate: 58%). 26 (9.3%), 66 (23.7%) and 40 (14.2%) patients met criteria for cancer-related PTSD, subthreshold PTSD and AjD, respectively. Symptom severity and frequency of criteria-based PTSD and AjD did not differ between SCT subgroups (all p > 0.05). Factors associated with elevated symptomatology were younger age (PTSD: p < 0.001; AjD: p = 0.02), physical comorbidity (PTSD: p < 0.001; AjD: p < 0.001) and active disease (PTSD: p = 0.12; AjD: p = 0.03). Based on new criteria, a considerable part of hematological cancer patients reports PTSD and AjD symptoms. Younger patients and patients with physical symptom burden might be particularly at risk and need to be monitored closely to enable effective treatment at an early stage. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Splenectomised Hodgkin lymphoma patients: does severe pneumococcal disease pose a problem today and what is the best long-term strategy?
- Author
-
Weibull, Caroline E., Sjöberg, Jan, Dickman, Paul W., and Björkholm, Magnus
- Subjects
HODGKIN'S disease ,SPLENECTOMY ,SCIENTIFIC observation ,CONFIDENCE intervals ,MOTIVATION (Psychology) ,STREPTOCOCCAL diseases ,RETROSPECTIVE studies ,DISEASE incidence ,STREPTOCOCCUS ,CANCER patients ,ABDOMINAL surgery ,DESCRIPTIVE statistics ,ODDS ratio ,LONGITUDINAL method ,PROPORTIONAL hazards models ,DISEASE complications - Abstract
The article focuses on assessing severe pneumococcal disease risks in splenectomized Hodgkin lymphoma patients from 1973 to 1995 in Sweden. Topics include the historical context of splenectomy, varying prophylactic measures in different countries, and the decreasing incidence of severe pneumococcal infections in more recent decades among splenectomized patients in Sweden.
- Published
- 2023
- Full Text
- View/download PDF
7. Association of patient-reported pain with survival in bladder cancer: a post-hoc analysis of the iBLAD trial.
- Author
-
Stormoen, Dag Rune, Taarnhøj, Gry Assam, Friis, Rasmus Blechingberg, Johansen, Christoffer, and Pappot, Helle
- Subjects
BLADDER tumors ,CANCER pain ,STATISTICS ,HEALTH outcome assessment ,METASTASIS ,CANCER patients ,DATA analysis ,OVERALL survival ,DISEASE complications - Abstract
The article discusses a post-hoc analysis of the iBLAD trial which investigated the association of patient-reported pain with survival in bladder cancer patients during and after oncological treatment. The study determined differences in age and follow-up time between male/female and locally advanced/metastatic patient groups using Mann-Whitney U test. It identified patient-reported symptoms, treatment outcomes and survival by disease stage, age, treatment and sex using Cox regression analysis.
- Published
- 2023
- Full Text
- View/download PDF
8. Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients.
- Author
-
Berger, Thomas, Noble, David J., Yang, Zhuolin, Shelley, Leila EA., McMullan, Thomas, Bates, Amy, Thomas, Simon, Carruthers, Linda J., Beckett, George, Duffton, Aileen, Paterson, Claire, Jena, Raj, McLaren, Duncan B., Burnet, Neil G., and Nailon, William H.
- Subjects
COMPUTER-assisted surgery ,HEAD & neck cancer ,MAGNETIC resonance imaging ,RISK assessment ,CANCER patients ,COMPARATIVE studies ,XEROSTOMIA ,RESEARCH funding ,PAROTID glands ,PREDICTION models ,RADIOTHERAPY ,LOGISTIC regression analysis ,RECEIVER operating characteristic curves ,DISEASE complications - Abstract
The irradiation of sub-regions of the parotid has been linked to xerostomia development in patients with head and neck cancer (HNC). In this study, we compared the xerostomia classification performance of radiomics features calculated on clinically relevant and de novo sub-regions of the parotid glands of HNC patients. All patients (N = 117) were treated with TomoTherapy in 30–35 fractions of 2–2.167 Gy per fraction with daily mega-voltage-CT (MVCT) acquisition for image-guidance purposes. Radiomics features (N = 123) were extracted from daily MVCTs for the whole parotid gland and nine sub-regions. The changes in feature values after each complete week of treatment were considered as predictors of xerostomia (CTCAEv4.03, grade ≥ 2) at 6 and 12 months. Combinations of predictors were generated following the removal of statistically redundant information and stepwise selection. The classification performance of the logistic regression models was evaluated on train and test sets of patients using the Area Under the Curve (AUC) associated with the different sub-regions at each week of treatment and benchmarked with the performance of models solely using dose and toxicity at baseline. In this study, radiomics-based models predicted xerostomia better than standard clinical predictors. Models combining dose to the parotid and xerostomia scores at baseline yielded an AUC
test of 0.63 and 0.61 for xerostomia prediction at 6 and 12 months after radiotherapy while models based on radiomics features extracted from the whole parotid yielded a maximum AUCtest of 0.67 and 0.75, respectively. Overall, across sub-regions, maximum AUCtest was 0.76 and 0.80 for xerostomia prediction at 6 and 12 months. Within the first two weeks of treatment, the cranial part of the parotid systematically yielded the highest AUCtest . Our results indicate that variations of radiomics features calculated on sub-regions of the parotid glands can lead to earlier and improved prediction of xerostomia in HNC patients. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
9. Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis – a population-based study.
- Author
-
Wettergren, Lena, Eriksson, Lars E., Bergström, Charlotta, Hedman, Christel, Ahlgren, Johan, Smedby, Karin E., Hellman, Kristina, Henriksson, Roger, and Lampic, Claudia
- Subjects
TUMOR treatment ,DYSPAREUNIA ,FEMALE reproductive organ diseases ,SEXUAL dysfunction ,MASTURBATION ,CROSS-sectional method ,HUMAN sexuality ,SEXUAL intercourse ,RISK assessment ,CANCER patients ,COMPARATIVE studies ,DISEASE prevalence ,DESCRIPTIVE statistics ,QUESTIONNAIRES ,TUMORS ,LOGISTIC regression analysis ,EMOTIONS ,HYPOACTIVE sexual desire disorder ,FEMALE reproductive organ tumors ,BREAST tumors ,PSYCHOLOGICAL distress ,BODY image ,DISEASE risk factors ,DISEASE complications ,ADULTS - Abstract
Self-reported sex problems among women diagnosed with reproductive and nonreproductive cancers before the age of 40 are not fully understood. This study aimed to determine sexual dysfunction in young women following a cancer diagnosis in relation to women of the general population. Furthermore, to identify factors associated with sexual dysfunction in women diagnosed with cancer. A population-based cross-sectional study with 694 young women was conducted 1.5 years after being diagnosed with cancer (response rate 72%). Potential participants were identified in national quality registries covering breast and gynecological cancer, lymphoma and brain tumors. The women with cancer were compared to a group of women drawn from the general population (N = 493). Sexual activity and function were assessed with the PROMIS® SexFS. Logistic regression was used to assess differences between women with cancer and the comparison group, and to identify factors associated with sexual dysfunction. The majority of the women with cancer (83%) as well as the women from the comparison group (87%) reported having had sex the last month (partner sex and/or masturbation). More than 60% of the women with cancer (all diagnoses) reported sexual dysfunction in at least one of the measured domains. The women with cancer reported statistically significantly more problems than women of the comparison group across domains such as decreased interest in having sex, and vaginal and vulvar discomfort. Women with gynecological or breast cancer and those receiving more intense treatment were at particular high risk of sexual dysfunction (≥2 domains). Concurrent emotional distress and body image disturbance were associated with more dysfunction. The results underscore the need to routinely assess sexual health in clinical care and follow-up. Based on the results, development of interventions to support women to cope with cancer-related sexual dysfunction is recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Prevalence and predictors of symptoms of anxiety and depression, and comorbid symptoms of distress in parents of childhood cancer survivors and bereaved parents five years after end of treatment or a child's death.
- Author
-
Wikman, Anna, Mattsson, Elisabet, von Essen, Louise, and Hovén, Emma
- Subjects
END of treatment ,MENTAL depression risk factors ,ANXIETY risk factors ,ANXIETY ,BEREAVEMENT ,CANCER patients ,CHI-squared test ,STATISTICAL correlation ,MENTAL depression ,DISEASE complications ,EXPERIENCE ,MULTIVARIATE analysis ,PSYCHOLOGY of parents ,POST-traumatic stress disorder ,REGRESSION analysis ,SEX distribution ,PSYCHOLOGICAL stress ,TIME ,COMORBIDITY ,TREATMENT effectiveness ,DESCRIPTIVE statistics ,CHILDREN - Abstract
Background: Symptoms of anxiety and depression and their comorbidity in parents of children diagnosed with cancer, particularly later in the cancer trajectory, need further study. The aim was to investigate the prevalence and predictors of symptoms of anxiety and depression in parents of childhood cancer survivors and bereaved parents, five years after end of treatment or a child's death and to investigate comorbidity between symptoms of anxiety, depression and posttraumatic stress. Material and methods: Participants were 132 parents (68 mothers, 64 fathers) of survivors and 37 bereaved parents (20 mothers, 17 fathers). Chi-square test and t-test were used to explore differences in symptoms of anxiety and depression. Comorbidity was explored using Pearson's correlations and Chi-square test. Multivariable hierarchical linear regressions were used to identify predictors of symptoms of anxiety and depression. Results: In parents of survivors, 20% reported anxiety and 14% reported depression. Corresponding figures among bereaved parents were 30% and 35%. Among parents of survivors reporting clinically relevant anxiety and depression, a larger proportion were mothers than fathers. No such difference was found among bereaved parents. Symptoms of anxiety, depression and posttraumatic stress were highly correlated (all r≥0.65, p<.001). Comorbid symptoms were reported by 7-11% of parents of survivors and 14-24% of bereaved parents. In multivariable analyses, more severe symptoms of depression were associated with anxiety, posttraumatic stress and distress related to previous stressful life events. Being a mother, symptoms of depression and posttraumatic stress were associated with more severe symptoms of anxiety. Conclusion: A subset of parents report clinically elevated symptoms of anxiety and depression, comorbid anxiety, depression and posttraumatic stress. Experiencing distress related to previous stressful life events as well as concurrent comorbidity were associated with more severe psychological distress at five years after end of treatment/a child's death. These results deserve further attention in research and clinical care. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
11. Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism.
- Author
-
Kiserud, Cecilie E., Seland, Mette, Holte, Harald, Foss, Alexander, Foss, Sophie D., Bollerslev, Jens, Bjøro, Trine, and Loge, Jon Håvard
- Subjects
CANCER complications ,HYPOTHYROIDISM diagnosis ,HYPOTHYROIDISM ,ANALYSIS of variance ,CANCER patients ,CHI-squared test ,CONFIDENCE intervals ,FATIGUE (Physiology) ,HEALTH surveys ,LYMPHOMAS ,QUESTIONNAIRES ,REGRESSION analysis ,RESEARCH funding ,T-test (Statistics) ,CROSS-sectional method ,DATA analysis software ,DESCRIPTIVE statistics ,ODDS ratio ,DISEASE complications ,DIAGNOSIS ,DISEASE risk factors - Abstract
Background. Few studies have explored fatigue in different groups of lymphoma survivors and the association with hormonal dysfunctions. The aims were to analyze associations between fatigue and thyroid and gonadal function in male lymphoma survivors. In addition, the impact of chronic fatigue on work situation and daily functioning were explored. Patients and methods. This cross-sectional study included male lymphoma survivors diagnosed in 1980-2002, aged ≤ 50 years at diagnosis and > 18 years at survey in 2007. The participants (n = 233, median age at survey: 48 years, median observation time: 15 years) completed questionnaires assessing levels of fatigue, chronic fatigue (duration ≥ 6 months), mental distress, daily functioning and work situation. Levels of thyroid and gonadal hormones were assessed. The participants were grouped according to diagnosis: Hodgkin lymphoma (HL, n = 131), aggressive/very aggressive non-Hodgkin lymphoma (NHL) (n = 67) and indolent NHL (n = 35). Thyroid hormones were categorized as normal (n = 174) or latent hypothyroidism (elevated thyroid stimulating hormone, n = 59). Gonadal hormones were categorized as normal (n = 111), elevated follicle stimulating hormone only (n = 45), primary (n = 35) or secondary hypogonadism (n = 42). Uni- and multivariate regression analyses were performed. A p value < 0.05 indicated the level of significance. Results. The survivors of HL and aggressive/very aggressive NHL had similar fatigue levels and similar prevalence of chronic fatigue (HL: 31%, aggressive/very aggressive; NHL: 27%). Survivors of indolent NHL had lower fatigue levels and prevalence of chronic fatigue (11%). Latent hypothyroidism was associated with increased fatigue levels (p = 0.042). Gonadal function was not associated with levels of fatigue or chronic fatigue. Mental distress was associated with increasing fatigue levels and chronic fatigue (p < 0.001). We found negative associations between chronic fatigue, daily functioning and work status. Conclusions. Fatigued lymphoma survivors should be investigated for thyroid function. The negative impact of chronic fatigue on daily functioning and work status emphasizes the importance of maintaining the effort in understanding the mechanisms behind fatigue. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
12. Harvest for health gardening intervention feasibility study in cancer survivors.
- Author
-
Blair, Cindy K., Madan-Swain, Avi, Locher, Julie L., Desmond, Renee A., de Los Santos, Jennifer, Affuso, Olivia, Glover, Tony, Smith, Kerry, Carley, Joseph, Lipsitz, Mindy, Sharma, Ayushe, Krontiras, Helen, Cantor, Alan, and Demark-Wahnefried, Wendy
- Subjects
CANCER patients ,DIET ,FRUIT ,GRIP strength ,HEALTH surveys ,HORTICULTURE ,QUALITY of life ,RESEARCH funding ,TUMORS ,VEGETABLES ,PILOT projects ,PHYSICAL activity ,DESCRIPTIVE statistics ,DISEASE complications - Abstract
Background. Cancer survivors are at increased risk for second malignancies, cardiovascular disease, diabetes, and functional decline. Evidence suggests that a healthful diet and physical activity may reduce the risk of chronic disease and improve health in this population. Methods. We conducted a feasibility study to evaluate a vegetable gardening intervention that paired 12 adult and child cancer survivors with Master Gardeners to explore effects on fruit and vegetable intake, physical activity, quality-of-life, and physical function. Throughout the year-long study period, the survivor-Master Gardener dyads worked together to plan/plant three gardens, harvest/rotate plantings, and troubleshoot/correct problems. Data on diet, physical activity, and quality-of-life were collected via surveys; anthropometrics and physical function were objectively measured. Acceptability of the intervention was assessed with a structured debriefing survey. Results. The gardening intervention was feasible (robust enrollment; minimal attrition) and well-received by cancer survivors and Master Gardeners. Improvement in three of four objective measures of strength, agility, and endurance was observed in 90% of survivors, with the following change scores [median (interquartile range)] noted between baseline and one-year follow-up: hand grip test [+ 4.8 (3.0, 6.7) kg], 2.44 meter Get-Up-and-Go [+ 1.0 (+ 1.8, + 0.2) seconds], 30-second chair stand [+ 3.0 (+ 1.0, 5.0) stands], and six-minute walk [+ 11.6 (6.1, 48.8) meters]. Increases of ≥ 1 fruit and vegetable serving/day and ≥ 30 minutes/week of physical activity were observed in 40% and 60%, respectively. Conclusion. These preliminary results support the feasibility and acceptability of a mentored gardening intervention and suggest that it may offer a novel and promising strategy to improve fruit and vegetable consumption, physical activity, and physical function in cancer survivors. A larger randomized controlled trial is needed to confirm our results. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
13. Self-reported work ability in long-term breast cancer survivors. A population-based questionnaire study in Denmark.
- Author
-
Carlsen, Kathrine, Jensen, Anette Jung, Rugulies, Reiner, Christensen, Jane, Bidstrup, Pernille Envold, Johansen, Christoffer, Huitfeldt Madsen, Ida Elisabeth, and Dalton, Susanne O.
- Subjects
BREAST tumors ,CANCER patients ,CHI-squared test ,CONFIDENCE intervals ,EMPLOYMENT ,EPIDEMIOLOGY ,QUESTIONNAIRES ,RESEARCH funding ,T-test (Statistics) ,DATA analysis ,MULTIPLE regression analysis ,CROSS-sectional method ,DATA analysis software ,DESCRIPTIVE statistics ,DISEASE complications - Abstract
Background. Although up to 80% of women can return to work after treatment for breast cancer, maintaining an affiliation to the labour market may be a challenge, as shown by the fact that the risks for unemployment and early retirement are increased in the years after treatment of cancer. It is important to understand the work problems experienced by cancer survivors, including their ability to work. The aim of this study was to determine whether the ability of long-term breast cancer survivors to work was different from that of a cancer-free control group. Material and methods. In this population-based cross-sectional questionnaire study, 776 breast cancer survivors were matched with 1552 cancer-free women. Women with breast cancer diagnosed in 1997-2000 were identified in the Danish Cancer Registry, and the cancer-free controls were sampled from the Central Population Registry. Work ability was measured from a single question on the 'work ability index'. Furthermore, the questionnaire contained questions on socioeconomic factors, health-related factors and factors related to the workplace. Results. The overall response rate was 57% (493 survivors and 830 controls). After exclusions, the study population consisted of 170 survivors and 391 controls. Women with a diagnosis of breast cancer who had survived at least five years and had returned to work reported significantly poorer work ability than cancer-free controls. In models with adjustment for socioeconomic factors, health-related factors and support at work, the factors most strongly associated with impaired work ability were low income, fatigue and little help and support from a supervisor. Conclusion. Our findings indicate that the work ability of long-term breast cancer survivors who are disease-free and back in work is impaired in comparison with that of cancer-free women. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
14. Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review.
- Author
-
Solheim, Tora S., Fearon, Kenneth C. H., Blum, David, and Kaasa, Stein
- Subjects
CACHEXIA ,CANCER patients ,MEDICAL databases ,INFORMATION storage & retrieval systems ,MEDICAL information storage & retrieval systems ,MEDLINE ,NONSTEROIDAL anti-inflammatory agents ,ONLINE information services ,TUMORS ,WEIGHT loss ,SYSTEMATIC reviews ,DESCRIPTIVE statistics ,DISEASE complications - Abstract
Background. There are no established treatments for cachexia. Recently it has been suggested that the evidence for non-steroidal anti-inflammatory (NSAID) treatment is sufficient to support its regular clinical use. Primary objective in this systematic review was to assess efficacy and safety of NSAID treatment in improving body weight and muscle mass in patients with cancer cachexia. Secondary objectives were to assess whether this treatment could improve other cachexia domains such as anorexia and food intake, catabolic drive and function. Material and methods. A systematic literature review of PubMed, EMBASE and Cochrane Central register of controlled trials database was carried out using both text words and MeSH/EMTREE terms. Results. Thirteen studies were included; all but two trials showed either improvement or stabilization in weight or lean body mass. Seven studies were without a comparator. Studies are generally small and a few are methodologically flawed, often due to multiple outcomes with excess risk of false positives. Conclusion. NSAIDs may improve weight in cancer patients with cachexia, and there is some evidence on effect on physical performance, self-reported quality of life and inflammatory parameters. Evidence is too frail to recommend NSAID for cachexia outside clinical trials. This is supported by the known side effects of NSAIDs, even though the reviewed literature report almost negligible toxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
15. A Delphi consensus study among patients and clinicians in the Netherlands on the procedure of informing young breast cancer patients about Fertility Preservation.
- Author
-
Garvelink, Mirjam M., ter Kuile, Moniek M., Louw, Leoni A., Hilders, Carina G. J. M., and Stiggelbout, Anne M.
- Subjects
FERTILITY ,DECISION making methodology ,BREAST tumors ,CANCER patients ,FISHER exact test ,FOCUS groups ,MEDICAL personnel ,PATIENTS ,SCALE analysis (Psychology) ,ACCESS to information ,DATA analysis software ,DESCRIPTIVE statistics ,DISEASE complications ,PSYCHOLOGY - Abstract
Background. The aim of this study was to obtain feedback from, and reach consensus among different experts who are or have been involved in information provision about FP, regarding the (procedure of) information provision about Fertility Preservation (FP) and use of a web-based decision aid (DA) about FP to create optimal conditions for the implementation of the DA-website, as we prepare to implement a DA about FP in the Netherlands. Material and methods. A two round Delphi study in which experts (patients and clinicians) rated their (dis)agreement with a list of statements (Rounds 1, 2), and additional online forum to discuss dissensus (Round 3). We assessed opinions about FP, web-based DAs, and about the procedure of informing patients. Answer categories ranged from 1 (totally disagree) to 5 (totally agree). Consensus was considered significant when at least 80% of the experts scored either the lowest or the highest two categories. Results. Experts reached rapid consensus on all five statements about the use of a DA (5/5; 100%), and all eight statements about which patients should be offered information about FP (8/8; 100%). However opinions about FP (4/11 statements; 36%), and procedural aspects such as who should inform the patient (6/10 statements; 60%) and when (3/10 statements; 30%) remained for discussion in round 3. In the online discussion some level of agreement was reached for these statements after all. Conclusion. It was deemed important that FP options exist. Every eligible patient should receive at least some (general) information about FP, soon after diagnosis. Detailed information should be provided by a fertility expert at a later moment. Exact timing and amount of information should be adjusted to patient's needs and situational context. A DA-website can offer a fair contribution to this. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
16. Factors associated with the prescription of antidepressive medication to breast cancer patients.
- Author
-
Suppli, Nis P., Deltour, Isabelle, Damkjær, Lars H., Christensen, Jane, Jensen, Anders B., Kroman, Niels T., Johansen, Christoffer, and Dalton, Susanne O.
- Subjects
ANTIDEPRESSANTS ,DISEASE progression ,ANALYSIS of variance ,BREAST tumors ,CANCER patients ,CANCER patient rehabilitation ,CHI-squared test ,COMPUTER software ,DATABASES ,MENTAL depression ,REPORTING of diseases ,RESEARCH funding ,RISK assessment ,SURVIVAL analysis (Biometry) ,T-test (Statistics) ,DATA analysis ,SCALE items ,SECONDARY analysis ,SOCIOECONOMIC factors ,PROPORTIONAL hazards models ,DISEASE complications ,PSYCHOLOGY - Abstract
We evaluated factors associated with use of antidepressant medication subsequent to a diagnosis of breast cancer. We also evaluated the effect of participation in a cancer rehabilitation program on use of antidepressants. Material and methods. We conducted a register-based cohort study of 1 247 women with breast cancer diagnosed between 1998 and 2006 who attended a week-long rehabilitation program and a comparison group of 2 903 women who did not attend the program matched through the registers of the Danish Breast Cancer Cooperative Group. The associations between breast cancer-related, treatment-related, and sociodemographic factors and use of antidepressants were evaluated in multivariate Cox proportional hazard models separated on use of antidepressants before diagnosis of breast cancer. Results. The mean follow-up for the 4 150 women in the study was 3.3 years (5-95% range, 0.3-7.0 years) and 1 020 (25%) were users of antidepressants after diagnosis of breast cancer. Among women who had not used antidepressants before their breast cancer, the diagnosis of a new primary cancer increased the adjusted hazard ratio (HR) to 3.34 (95% CI, 1.50-7.76), and recurrence of breast cancer increased the HR for first use of antidepressants to 2.56 (95% CI, 1.86-3.52). Unemployment was associated significantly with use of antidepressants, whereas having no children living at home, lower income, and the number of tumor-positive axillary lymph nodes were of borderline significance. No effect of the rehabilitation program was observed on first use of antidepressants after breast cancer. Discussion. Diagnosis of a new cancer or recurrence of breast cancer considerably increased the rate of use of antidepressants. Sociodemographic rather than disease- or treatment-related characteristics at the time of diagnosis were associated with first use of antidepressants after a breast cancer diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.